OpGen Presentations & Investor Relations material

OpGen, Inc. (NASDAQ: OPGN) is harnessing the power of informatics and genomic analysis to provide complete solutions for infection prevention and treatment. Using our large and ever-growing Acuitas Lighthouse® Knowledgebase of pathogens from around the world, we are developing disruptive technologies aimed to shift the paradigm for managing infectious diseases. Today, through our CLIA-certified clinical laboratory services, we provide rapid detection and analysis of antibiotic resistance and high resolution microbial sequence analysis. Our FDA-cleared, IVD products rapidly identify pathogens in positive blood cultures.